학술논문
Frequency and prognostic impact of alk amplifications and mutations in the european neuroblastoma study group (siopen) high-risk neuroblastoma trial (hr-nbl1)
Document Type
Article
Author
Bellini, A.; Bhalshankar, J.; Clement, N.; Jimenez, I.; Schleiermacher, G.; Delattre, O.; Potschger, U.; Ambros, P.F.; Bernkopf, M.; Taschner-Mandl, S.; Bernard, V.; Baulande, S.; Lapouble, E.; Pierron, G.; Auger, N.; Beiske, K.; Betts, D.R.; Bown, N.; De Preter, K.; Van Roy, N.; Combaret, V.; De Mora, J.F.; George, S.L.; Jeison, M.; Marques, B.; Martinsson, T.; Mazzocco, K.; Morini, M.; Muhlethaler-Mottet, A.; Noguera, R.; Rossing, M.; Vicha, A.; Malis, J.; Chesler, L.; Balwierz, W.; Castel, V.; Elliott, M.; Kogner, P.; Laureys, G.; Luksch, R.; Popovic-Beck, M.; Ash, S.; Valteau-Couanet, D.; Tweddle, D.A.; Ladenstein, R.
Source
In: Journal of Clinical Oncology . (Journal of Clinical Oncology, 20 October 2021, 39(30):3377-3390)
Subject
Language
English
ISSN
15277755
0732183X
0732183X